EP3773299A1 - Optimierung einer bph-behandlung mittels hoelp (holium-laser-enukleation der prostata) - Google Patents

Optimierung einer bph-behandlung mittels hoelp (holium-laser-enukleation der prostata)

Info

Publication number
EP3773299A1
EP3773299A1 EP19774625.8A EP19774625A EP3773299A1 EP 3773299 A1 EP3773299 A1 EP 3773299A1 EP 19774625 A EP19774625 A EP 19774625A EP 3773299 A1 EP3773299 A1 EP 3773299A1
Authority
EP
European Patent Office
Prior art keywords
pulses
laser
target tissue
bubble
distal
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
EP19774625.8A
Other languages
English (en)
French (fr)
Other versions
EP3773299A4 (de
EP3773299B1 (de
Inventor
Arkady Khachaturov
Tal Waisman
Eyal BENISTY
Mikhael Feldchtein
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Lumenis BE Ltd
Original Assignee
Lumenis Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lumenis Ltd filed Critical Lumenis Ltd
Priority to EP25164034.8A priority Critical patent/EP4602999A3/de
Publication of EP3773299A1 publication Critical patent/EP3773299A1/de
Publication of EP3773299A4 publication Critical patent/EP3773299A4/de
Application granted granted Critical
Publication of EP3773299B1 publication Critical patent/EP3773299B1/de
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B18/00Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
    • A61B18/18Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by applying electromagnetic radiation, e.g. microwaves
    • A61B18/20Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by applying electromagnetic radiation, e.g. microwaves using laser
    • A61B18/22Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by applying electromagnetic radiation, e.g. microwaves using laser the beam being directed along or through a flexible conduit, e.g. an optical fibre; Couplings or hand-pieces therefor
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B18/00Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
    • A61B18/18Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by applying electromagnetic radiation, e.g. microwaves
    • A61B18/20Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by applying electromagnetic radiation, e.g. microwaves using laser
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B18/00Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
    • A61B18/18Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by applying electromagnetic radiation, e.g. microwaves
    • A61B18/20Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by applying electromagnetic radiation, e.g. microwaves using laser
    • A61B18/22Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by applying electromagnetic radiation, e.g. microwaves using laser the beam being directed along or through a flexible conduit, e.g. an optical fibre; Couplings or hand-pieces therefor
    • A61B18/24Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by applying electromagnetic radiation, e.g. microwaves using laser the beam being directed along or through a flexible conduit, e.g. an optical fibre; Couplings or hand-pieces therefor with a catheter
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B1/00Instruments for performing medical examinations of the interior of cavities or tubes of the body by visual or photographical inspection, e.g. endoscopes; Illuminating arrangements therefor
    • A61B1/06Instruments for performing medical examinations of the interior of cavities or tubes of the body by visual or photographical inspection, e.g. endoscopes; Illuminating arrangements therefor with illuminating arrangements
    • A61B1/07Instruments for performing medical examinations of the interior of cavities or tubes of the body by visual or photographical inspection, e.g. endoscopes; Illuminating arrangements therefor with illuminating arrangements using light-conductive means, e.g. optical fibres
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B1/00Instruments for performing medical examinations of the interior of cavities or tubes of the body by visual or photographical inspection, e.g. endoscopes; Illuminating arrangements therefor
    • A61B1/307Instruments for performing medical examinations of the interior of cavities or tubes of the body by visual or photographical inspection, e.g. endoscopes; Illuminating arrangements therefor for the urinary organs, e.g. urethroscopes, cystoscopes
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B18/00Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
    • A61B18/18Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by applying electromagnetic radiation, e.g. microwaves
    • A61B18/20Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by applying electromagnetic radiation, e.g. microwaves using laser
    • A61B18/22Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by applying electromagnetic radiation, e.g. microwaves using laser the beam being directed along or through a flexible conduit, e.g. an optical fibre; Couplings or hand-pieces therefor
    • A61B18/26Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by applying electromagnetic radiation, e.g. microwaves using laser the beam being directed along or through a flexible conduit, e.g. an optical fibre; Couplings or hand-pieces therefor for producing a shock wave, e.g. laser lithotripsy
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods
    • A61B2017/00017Electrical control of surgical instruments
    • A61B2017/00022Sensing or detecting at the treatment site
    • A61B2017/00057Light
    • A61B2017/00066Light intensity
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B18/00Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
    • A61B2018/00053Mechanical features of the instrument of device
    • A61B2018/00214Expandable means emitting energy, e.g. by elements carried thereon
    • A61B2018/0022Balloons
    • A61B2018/00226Balloons extending from a surface, i.e. Blisters
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B18/00Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
    • A61B2018/00315Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body for treatment of particular body parts
    • A61B2018/00505Urinary tract
    • A61B2018/00511Kidney
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B18/00Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
    • A61B2018/00315Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body for treatment of particular body parts
    • A61B2018/00547Prostate
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B18/00Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
    • A61B2018/00571Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body for achieving a particular surgical effect
    • A61B2018/00625Vaporization
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B18/00Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
    • A61B2018/00636Sensing and controlling the application of energy
    • A61B2018/00642Sensing and controlling the application of energy with feedback, i.e. closed loop control
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B18/00Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
    • A61B2018/00636Sensing and controlling the application of energy
    • A61B2018/00696Controlled or regulated parameters
    • A61B2018/00702Power or energy
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B18/00Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
    • A61B2018/00636Sensing and controlling the application of energy
    • A61B2018/00773Sensed parameters
    • A61B2018/00779Power or energy
    • A61B2018/00785Reflected power
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B18/00Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
    • A61B2018/00982Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body combined with or comprising means for visual or photographic inspections inside the body, e.g. endoscopes
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B18/00Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
    • A61B18/18Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by applying electromagnetic radiation, e.g. microwaves
    • A61B18/20Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by applying electromagnetic radiation, e.g. microwaves using laser
    • A61B2018/2015Miscellaneous features
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B18/00Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
    • A61B18/18Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by applying electromagnetic radiation, e.g. microwaves
    • A61B18/20Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by applying electromagnetic radiation, e.g. microwaves using laser
    • A61B2018/206Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by applying electromagnetic radiation, e.g. microwaves using laser the laser light passing along a liquid-filled conduit
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B18/00Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
    • A61B18/18Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by applying electromagnetic radiation, e.g. microwaves
    • A61B18/20Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by applying electromagnetic radiation, e.g. microwaves using laser
    • A61B18/22Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by applying electromagnetic radiation, e.g. microwaves using laser the beam being directed along or through a flexible conduit, e.g. an optical fibre; Couplings or hand-pieces therefor
    • A61B2018/2205Characteristics of fibres
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B18/00Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
    • A61B18/18Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by applying electromagnetic radiation, e.g. microwaves
    • A61B18/20Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by applying electromagnetic radiation, e.g. microwaves using laser
    • A61B18/22Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by applying electromagnetic radiation, e.g. microwaves using laser the beam being directed along or through a flexible conduit, e.g. an optical fibre; Couplings or hand-pieces therefor
    • A61B18/26Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by applying electromagnetic radiation, e.g. microwaves using laser the beam being directed along or through a flexible conduit, e.g. an optical fibre; Couplings or hand-pieces therefor for producing a shock wave, e.g. laser lithotripsy
    • A61B2018/263Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by applying electromagnetic radiation, e.g. microwaves using laser the beam being directed along or through a flexible conduit, e.g. an optical fibre; Couplings or hand-pieces therefor for producing a shock wave, e.g. laser lithotripsy the conversion of laser energy into mechanical shockwaves taking place in a liquid

Definitions

  • the present invention is directed to laser devices useful in the treatment of benign prostate hyperplasia (BPH), and in particular devices useful, for example, in performing laser enucleation of the prostate (LEP), which, when performed using a Holmium laser device is abbreviated as HoLEP and when performed using a Thulium laser device is abbreviated as ThuLEP.
  • LAP laser ablation of the prostate
  • HoLAP Holmium laser
  • This invention relates to laser light energy sources and to methods and devices for reducing the attenuation of a laser beam which will transit through a liquid environment to a target tissue in laser lithotripsy, reduction of optical fiber arrangementk and target tissue retropulsion, LEP and other relevant fields where a laser is used in a liquid environment.
  • Benign Prostatic Hyperplasia has been treated successfully using a well- known laser enucleation procedure, a procedure (known is the industry as“LEP”) in which the grown prostate tissue (prostatic adenoma) is separated from its surrounding prostatic capsule and other organs such as seminal colliculus and other landmarks, by cutting into the prostate without harming the capsule itself.
  • the separated tissue usually cut into a number of pieces, is then pushed into the bladder.
  • the pieces may then be morcellated using a mechanical morcellation device to grind up the pieces to a size in which they can be removed from the body.
  • a device such as that described in pending US Patent Application Serial No. 15/710,316, filed September 20, 2017 and entitled “System and Method for Morcellation of Tissue” (which application is herein
  • tissue removal task may be suitable for performing this tissue removal task.
  • laser-based morcellation devices may be employed. The entire procedure is performed, using endoscopic techniques through natural body orifices.
  • the LEP procedure has been found to be very beneficial for the patient because it has generally a very low reoperation rate due to the fact that there is no prostate regrowth because all of the prostate tissue is removed, unlike other types of procedures (like TURP). Due to the very low complication rate, the patient’s recovery is quicker and less painful than some other procedures.
  • an incision may be made through the prostate tissue to reach the capsule. This is usually done at predetermined positions to help the surgeon’s orientation, e.g., at“1 o’clock”,“11 o’clock” positions. Some physicians are practicing different cuts such as“5 o’clock” and“7 o’clock”,“12 o’clock” or others. After the prostate-capsule border is reached, the surgeon may fire the laser along the anatomical boundaries of the prostate gland material and the capsule, thus creating a separating plane between the two.
  • an optical fiber is inserted through a working channel of a ureteroscope as well as irrigation and visualization systems.
  • the working environment of a laser radiation emitted from a tip of the optical fiber toward a target tissue is therefore a liquid environment.
  • Liquid environment tends to absorb optical energy and therefore may affect both, the adjacent liquid environment itself as well as the
  • the laser When the laser is fired, it may create a vapor bubble in front of the fiber tip, the bubble being caused by the laser vaporizing the liquid material present at the site, as described in the aforementioned US Patent Application Serial No. 16/177,800.
  • one or more vapor bubbles created by the laser device are used to create a “pathway” to, in such procedures, break up or disintegrate, for example, kidney stones or other abnormal growths that may be present and“floating around” the urinary tract, the kidneys or the bladder.
  • a more efficient treatment may result due to the absence of liquid in the“pathway”.
  • a surgeon may be able to create one or more bubbles with the laser in the liquid working environment during a LEP procedure and employ the vapor bubble created by the laser pulse to mechanically cut the prostate or separate it from its capsule or other organs.
  • the one or more bubbles’ path to the target tissue may allow for easier visual tracking of the laser cutting plane.
  • the equipment 100 includes an optical laser fiber or a light guide 102 connected at its proximal end 104 to a laser source 106, which may be a laser source such as
  • the laser fiber or the light guide 102 is passed through an endoscope 108 and its distal end or tip 110 extends out from the distal end 112 of the endoscope.
  • Regular mode pulses fire a continuous amount of energy from the fiber distal end 110 into the liquid environment surrounding the fiber, and between the fiber and the target tissue 114. This firing causes the inflation of a growing bubble followed by its collapse, typically a symmetrical bubble 116 is inflated, with its center positioned about the fiber tip 110.
  • Fig. 1 One problem associated with this prior art setup of Fig. 1 is the negative effects that the bubble(s) may cause both to the fiber tip and to the distal end of the endoscope.
  • the vapor bubble 116 as seen in Fig. 1, expands not only toward the target tissue but backwards as well and this bubble with its contained energy may impact the distal end of the endoscope, and during its collapse may impact the fiber or even the ureteroscope itself, thus creating fiber so-called“burnback” or degradation of the fiber.
  • Fiber burnback is a known condition that may cause the fiber tip to degrade to such an extent so as to impede or at least make less efficient the treatment parameters.
  • the backward development of the bubble represents optical energy loss which was absorbed by the liquid but has not improved the MOSESTM effect and therefore lessens the efficiency of the tissue treatment by reducing the energy available to impact the treatment of the target tissue such as, for example, prostate or urinary tract stone.
  • a step 400 in which the user may select a“pair of pulses” repetition rate is described in relation to Fig. 3B, a step 400 in which the user may select a“pair of pulses” repetition rate.
  • the specification further describes this step 400 as the repetition rate between pairs of pulses, one of which may be a bubble initiation pulse and the second a treatment pulse. It has been found that by manipulating the timing of the pairs of pulses that better treatment parameters may be had. It is further to this goal that the present invention is also directed.
  • a method of treating a target tissue with a laser beam, the target tissue being immersed in a liquid medium within a body lumen includes:
  • providing a laser device for generating a laser beam providing an endoscope configured to be introduced into the body lumen, the endoscope having a distal end portion;
  • an optical fiber or a light guide configured to be contained in the endoscope and having a distal delivery end for guiding the laser beam to the target tissue, wherein the distal delivery end protrudes a distance from the distal end portion of the endoscope; and providing a controller for causing the laser device to generate one or more laser pulses substantially along the same longitudinal axis.
  • a side firing fiber or wave guide may be used.
  • the controller causes the laser device to provide one or more laser pulses, the one or more laser pulses being configured by the controller to have an energy sufficient to form one or more vapor bubbles in the liquid medium at the distal delivery end of the fiber; the one or more pulses are configured by the controller to: first, causing a vapor bubble to be formed distally of the distal end portion of the endoscope and around the distal delivery end of the optical fiber or a light guide; second, causing a second vapor bubble to be formed distally of the first bubble, the second vapor bubble being distal of both the endoscope distal end portion and the optical fiber distal delivery end; and third, inflating the second bubble as the first bubble has begun to collapse to expand an amount sufficient to displace a substantial portion of the liquid medium from the space between the distal delivery end of the fiber and the target tissue, the one or more pulses being delivered to the target tissue through the inflated second bubble; the displacement of the second bubble away from the distal portion of the endoscope and the distal delivery end of the optical
  • an apparatus for the treatment of a target tissue with a laser beam in which the target tissue is immersed in a liquid medium within a body lumen, includes: a laser device for generating a laser beam; an endoscope configured to be introduced into the body lumen, the endoscope having a distal end portion; an optical fiber or light guide configured to be contained in the endoscope and having a distal delivery end for guiding the laser beam to the target tissue, wherein the distal delivery end protrudes a distance from the distal end portion of the endoscope; a controller for causing the laser device to generate one or more laser pulses substantially along or aside the same longitudinal axis.
  • the laser device is configured to provide one or more laser pulses, the one or more laser pulses being configured by the controller to have an energy sufficient to form one or more vapor bubbles in the liquid medium at the distal delivery end of the fiber.
  • the one or more pulses are configured by the controller to: first, cause a vapor bubble to be formed distally of the distal end portion of the endoscope and around the distal delivery end of the optical fiber or a light guide; second, cause a second vapor bubble to be formed distally of the first bubble, the second vapor bubble being distal of both the endoscope distal end portion and the optical fiber distal delivery end; third, inflate the second bubble as the first bubble has begun to collapse to expand an amount sufficient to displace a substantial portion of the liquid medium from the space between the distal delivery end of the fiber and the target tissue, the one or more pulses being delivered to the target tissue through the inflated second bubble.
  • the one or more laser pulses is more than one train of pulses
  • the method further comprising the step of the controller of selecting a repetition rate for delivery of the more than one laser pulses.
  • the method also may include selecting at least one of the following parameters through the controller: selecting the total energy of one or more pulses to be delivered to the target tissue, selecting the pulse length of one or more pulses to be delivered to the target tissue, selecting the pulse energy, selecting the time delay between successive train of one or more pulses, selecting the laser
  • wavelength (wavelength) to be used for a one or more pulses, selecting the fiber size, selecting the required clinical result and selecting the distance from the delivery end to the target tissue.
  • the method may further include the steps of: measuring actual energy irradiated by the laser device; comparing the actual measured energy to a total energy selected by the controller; and, if the comparison demonstrates variance of the actual measured energy from the selected total energy, the controller adjusting the energy or pulse length for any following pulses to achieve the selected energy delivered to the target tissue.
  • the target tissue may be a tissue, an organ or a formed stone within a human body.
  • the method may also include the step of selecting and mounting on the laser device an optical fiber or a light guide type to be used in irradiating the target tissue.
  • the type of optical fiber or wave guide includes at least one of the parameters of: fiber diameter, fiber material, fiber numerical aperture and shape of the distal delivery end.
  • the step of selecting the distance from the delivery end to the target tissue may include the further step of measuring the distance and selecting the measured distance.
  • the step of measuring the actual energy delivered by the laser is performed by a photodetector in the light path of the laser radiation or in the light path of back scattered laser light from a target tissue.
  • the step of the controller adjusting the energy is accomplished by a closed loop feedback circuit operatively connected to the controller.
  • the controller may intermittently recognize parameters associated with the fiber type mounted on the laser device.
  • the step of automatically recognizing is performed by a RFID identification tag mounted on the delivery device and on the waveguide or optical fiber.
  • the controller may indicate on a user interface associated with the controller if the optical fiber type is compatible with a treatment selected.
  • a method of treating a target tissue with a laser beam in which the target tissue is immersed in a liquid medium within a body lumen or in which the laser beam has to cross a liquid medium on its way to a target tissue, includes:
  • a laser device for generating a laser beam; providing an optical fiber or a light guide having a distal delivery end for guiding the laser beam to the target tissue; providing a controller for causing the laser device to generate one or more laser pulses substantially along or lateral to the same longitudinal axis; the controller causing the laser device to provide a plurality of laser pulses, the plurality of laser pulses being configured by the controller to have an energy sufficient to form one or more vapor bubbles in the liquid medium at the distal delivery end of the fiber; the plurality of laser pulses may be selected by the controller to allow the one or more vapor bubbles to expand an amount sufficient to displace a substantial portion of the liquid medium from the space between the delivery end of the fiber and the target tissue, the plurality of pulses being delivered to the target tissue through the one or more vapor bubbles, wherein time intervals between adjacent pulses of the plurality of pulses are non-uniform.
  • the treatment may be prostate enucleation, and one or more pulses may be first configured for mechanical tissue separation, followed by one or more pulses configured to incise the mechanically separated tissue.
  • the treatment may be stone lithotripsy to diminish kidney stones, and wherein one or more pulses are first configured to cause cavitation to bring stones in front of the laser fiber, followed by a series of low energy, high repetition rate pulses to effect stone dusting to diminish kidney stones.
  • the treatment may be prostate enucleation or vaporization, and one or more pulses may be first configured to one or more of incising or ablating the target tissue, followed by one or more pulses configured to coagulate the tissue one or more of incised or ablated.
  • an apparatus for treating a target tissue with a laser beam in which the target tissue may be immersed in a liquid medium within a body lumen or in which the laser beam has to cross a liquid medium on its way to a target tissue, includes: a laser device for generating a laser beam; an optical fiber or a light guide having a distal delivery end for guiding the laser beam to the target tissue; a controller configured to cause the laser device to generate one or more laser pulses substantially along the same longitudinal axis or laterally; the controller is further configured to cause the laser device to provide a plurality of laser pulses, the plurality of laser pulses being configured by the controller to have an energy sufficient to form one or more vapor bubbles in the liquid medium at the distal delivery end of the fiber; the plurality of laser pulses may be configured by the controller to allow the one or more vapor bubbles to expand an amount sufficient to displace a substantial portion of the liquid medium from the space between the delivery end of the fiber and the target tissue, the plurality of pulses being delivered
  • the treatment may be prostate enucleation, and wherein one or more pulses are first configured for mechanical tissue separation, followed by one or more pulses configured to incise the mechanically separated tissue.
  • the treatment may be stone lithotripsy to diminish kidney stones, and wherein one or more pulses are first configured to cause cavitation to bring stones in front of the laser fiber or the light guide, followed by a series of low energy, high repetition rate pulses to effect stone dusting to diminish kidney stones.
  • the treatment may be prostate enucleation or vaporization, and wherein one or more pulses are first configured to one or more of incising or ablating the target tissue, followed by one or more pulses configured to coagulate the tissue one or more of incised or ablated.
  • apparatus for the treatment of a target tissue with a laser beam in which the target tissue being immersed in a liquid medium within a body lumen or in which the laser beam has to cross a liquid medium on its way to a target tissue, includes: a laser device for generating a laser beam; an endoscope configured to be introduced into the body lumen, the endoscope having a distal end portion; an optical fiber configured to be contained in the endoscope and having a distal delivery end for guiding the laser beam to the target tissue, wherein the distal delivery end protrudes a distance from the distal end portion of the endoscope.
  • a tubular hollow choke may be configured to be mounted onto one of: the distal delivery end of the optical fiber or light guide or the distal end portion of the endoscope; the choke may be configured, when the laser device generates a laser beam, to shape a vapor bubble formed distally of one of: the distal end portion of the endoscope or the distal end of the optical fiber or light guide.
  • the tubular hollow choke may be one of: cylindrical or tapering frustoconical shape.
  • the tapering may be either tapered to increase or decrease from a proximal end to a distal end of the frustoconical shaped hollow choke.
  • Fig. 1 illustrates a representation of a prior art device.
  • Fig. 2 illustrates an aspect of bubble formation of the present invention.
  • Figs. 3A through 3C illustrate a sequence of the formation of bubbles in connection with the present invention.
  • Fig. 3D is a graphical representation of bubble formation in the present invention.
  • Figs. 4A through 4C illustrate timing aspects of pulse formation in the present invention.
  • Figs. 5A though 5D illustrate various chokes which may be utilized at the distal ends of either an optical fiber or an endoscope.
  • FIG. 2 this figure illustrates one embodiment of the present invention in which a vapor bubble has been moved distally from a position in which it impinges on both the fiber tip and the endoscope, as in Fig. 1, to a position shown in Fig. 2 in which the bubble 202 has been distanced from the endoscope 200 tip and the fiber tip 204 and closer to the target tissue 206.
  • the bubble 202 is positioned to be formed further away distally from both the endoscope and the fiber.
  • a bubble tends to be developed around the tip of a fiber at its center. Since a bubble created by the laser also tends to collapse to its center through cavitation, it may damage the tip of the fiber or the adjacent tip of the scope. The larger the bubble, the larger the potential of damaging.
  • the advantage of moving a bubble formation location distally is that when the bubble collapses it is not collapsed on the tip of the fiber or scope and may cause stronger photo-mechanical effects on a target tissue.
  • Another advantage is that the bubble does not impact the endoscope 200 or cause burnback of the fiber tip 204, thus reducing the possibility of damage and wear-and-tear. Also, as the bubble collapses towards its center, which is located away from the fiber tip, this reduces fiber tip burnback and degradation due to the bubble collapse shockwaves.
  • a first laser pulse is initiated through fiber 300 to create a small bubble 302 around the tip 304 of the fiber 300.
  • a second laser pulse is initiated to create a second bubble 306 which forms distally of the first bubble 302, as seen in Fig. 3B.
  • the first bubble 302 collapses, the second bubble 306 grows in dimensions.
  • a larger, second-distal bubble which is larger than the first-proximal bubble is a preferred result to push away from the tip of the scope and the fiber the damaging cavitation forces.
  • that bubble 306 does not touch or be centered around the fiber tip 304 or the endoscope tip for that matter.
  • a typical bubble dynamic over time The pressure inside a developed bubble is qualitatively represented by line a’ and the bubble diameter is qualitatively represented by line b’. It can be seen that at the initiation of the bubble there is a high pressure inside the bubble which is reduced as the diameter of the bubble grows. At some point of equilibrium with the surrounding ambient pressure, the bubble stops its growth and the vapor inside starts to cool down. This eventually leads to the opposite dynamic in which the diameter starts to decrease, and the internal pressure starts to grow again. This process ends as a cavitation.
  • the first bubble is centralized around the tip of the fiber and since by nature the bigger the bubble the stronger the cavitation energy, it is one aspect of the invention to initiate a first, smaller, bubble and a second, bigger,“main” bubble.
  • the pressure inside the second formed bubble is qualitatively represented by line a”, and the bubble diameter is qualitatively represented by line b”. Therefore, according to an aspect of the present invention, a first bubble is created, and a second bubble is created in a certain time delay, in a certain time window thereafter, so that the increased pressure of the first bubble during its collapse will promote the inflation of the second bubble.
  • the regime may be three pulses in seriatim.
  • the first and second pulses may be utilized to form and maintain the bubble and the third pulse utilized as a treatment pulse.
  • the present invention is not restricted to three pulses but could be any number as dictated by such factors as the type of treatment, the energy of the respective pulses, the liquid environment, the distance from the fiber tip to the target tissue, etc.
  • the laser may fire a train of laser pulses, which may use identical settings for each pulse, and may use a constant repetition rate, as seen in Fig. 4A, in which the symbol T at 400 represents the time period between successive pairs of pulses 402a,
  • a pulse regime may be created to generate a periodic train of pulses packet, in which each pulse in the packet may have different parameters, and the spacing of the pulses within the packet can be varied as well, as illustrated graphically in Fig. 4B.
  • Each pulse designated as pulse MOSESTM 1, 2, k shown in Fig. 4B may vary from other ones by the number of sub-pulses (as mentioned typically MOSESTM is implemented in a two sub pulse regime), total energy, energy distribution between sub-pulses, as well as time intervals between sub -pulses.
  • the interleaving described in connection with Fig. 4B enables optimized combination of properties of different pulse modes, to achieve an improved tissue effect, relative to what is possible with a non-interleaved progression of identical pulses, such as tissue mechanical separation, tissue thermal ablation or tissue thermal coagulation.
  • MOSESTM pulses may be used to optimize the amount of optical energy delivered to a target tissue or the liquid medium for the purpose of ablation, coagulation or creating an optical-mechanical effect in a target tissue.
  • a train of pulses may consist of a first one or more sub-pulses, which are configured to generate a first bubble centered on tip of an optical fiber and may be followed by a second one or more sub-pulses, which are configured to generate a second bubble.
  • the first bubble spaces the second bubble so that the center of the second bubble is longitudinally displaced from the tip of the optical fiber.
  • the collapse of the second bubble therefore, reduces the burnback of the fiber and may increase the mechanical separation of a target tissue.
  • the one or more first pulses may be generated with a laser having a first wavelength and the one of more second pulses may be generated by a laser having a second wavelength.
  • the first laser wavelength and the second laser wavelength are the same and may be generated by the same type of laser such as for example
  • the first laser wavelength and the second laser wavelength are different.
  • the first laser wavelength may be a Thulium laser wavelength and the second laser wavelength may be a Holmium laser wavelength.
  • some possible uses of this technique may include: 1. Stone lithotripsy - popcorn mode. In this mode the convection of the fluids is used to bring stones in front of the fiber, which are then broken by laser pulses. The convection is caused by laser pulses, which in this case should have a large bubble. The stone breaking is best done by MOSESTM mode pulses, e.g. low energy high repetition rate“dusting mode” settings, which do not cause sufficient convection. Interleaving pulses optimized to cause cavitation with pulses optimized for stone dusting can significantly improve pop-coming, or pop-dusting procedures.
  • Prostate enucleation - improved tissue separation In this mode several pulses can be placed close together within the packet. Some of the pulses can be optimized to provide best mechanical tissue separation (photo-mechanical effect), while the following pulses can be optimized for best tissue cutting (photo-thermal effect). In this way the first pulses“stretch” the tissue, preparing it for the following pulses, which do the incision more effectively.
  • Prostate enucleation or ablation - improves hemostasis. This combination can be used for treating vascular prostates. Some pulses of the packet will be optimized for best tissue treatment (incision or ablation), while the following will be optimized for best coagulative properties.
  • a bubble shaping element may be configured to shape one or more bubbles created at the tip of an optical fiber during laser treatment in a liquid environment.
  • Bubble shaping elements such as bubble shaping elements 502, 510, 512 and 514, may be mounted or attached to the distal portion of the endoscope 500 or the fiber 508 and has a proximal end 504 which is configured to be connected or engaged with an area adjacent a distal end of an optical fiber 508 or the distal end of the endoscope 500.
  • a distal end of the fiber shaping element is configured to allow fluid communication between an inner cavity in the bubble shaping element and the treatment surroundings.
  • the bubble shaping elements 502, 510, 512 and 514 restrict one or more bubbles from expanding along an axis which is approximately perpendicular to the longitudinal axis 516 of the optical fiber and allows a bubble 600 to grow along the longitudinal axis 516 of the optical fiber.
  • the bubble shaping element may have a diverging shape (502), a converging shape (510), a straight shape (512), have a narrow cross-section (514), or be in a frustoconical shape or other shapes in order to control the bubble dimensions and formation.
  • the bubble shaping elements shown in Figs. 5A through 5D allow a bubble 600 to grow more along an axis which connects the distal end of an optical fiber and a target tissue and restricts the growth of the bubble 600 along an axis approximately
  • the bubble shaping element allows improving the ratio between the amount of energy needed to create a bubble and the longitudinal size of the bubble.
  • optimization means that the less energy is“wasted” to develop a bubble and to grow the bubble until it reaches a target tissue in order to create the required MOSESTM or other desired effect; more energy is then available to be delivered through the bubble into the target tissue in order to get the desired treatment effects.
  • an adjustable choke may be implemented, much the same as the adjustable chokes employed on shotguns, by which a mechanism is adjusted to change the shape of the choke to suit particular treatment parameters.

Landscapes

  • Health & Medical Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Surgery (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Optics & Photonics (AREA)
  • Heart & Thoracic Surgery (AREA)
  • General Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Electromagnetism (AREA)
  • Medical Informatics (AREA)
  • Molecular Biology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Otolaryngology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Laser Surgery Devices (AREA)
  • Radiation-Therapy Devices (AREA)
  • Surgical Instruments (AREA)
  • Laser Beam Processing (AREA)
  • Treatments Of Macromolecular Shaped Articles (AREA)
EP19774625.8A 2018-03-29 2019-03-28 Optimierung einer benignen prostatahyperplasie (bph)-behandlung mittels holium-laser-enukleation der prostata (holep) Active EP3773299B1 (de)

Priority Applications (1)

Application Number Priority Date Filing Date Title
EP25164034.8A EP4602999A3 (de) 2018-03-29 2019-03-28 Optimierung der bph-behandlung mit lochp (holium laser enukleation von prostrat)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201862649930P 2018-03-29 2018-03-29
PCT/IL2019/050362 WO2019186564A1 (en) 2018-03-29 2019-03-28 Optimization of bph treatment using hoelp (holium laser enucleation of prostrate)

Related Child Applications (2)

Application Number Title Priority Date Filing Date
EP25164034.8A Division EP4602999A3 (de) 2018-03-29 2019-03-28 Optimierung der bph-behandlung mit lochp (holium laser enukleation von prostrat)
EP25164034.8A Division-Into EP4602999A3 (de) 2018-03-29 2019-03-28 Optimierung der bph-behandlung mit lochp (holium laser enukleation von prostrat)

Publications (3)

Publication Number Publication Date
EP3773299A1 true EP3773299A1 (de) 2021-02-17
EP3773299A4 EP3773299A4 (de) 2021-12-22
EP3773299B1 EP3773299B1 (de) 2025-06-25

Family

ID=68058099

Family Applications (2)

Application Number Title Priority Date Filing Date
EP19774625.8A Active EP3773299B1 (de) 2018-03-29 2019-03-28 Optimierung einer benignen prostatahyperplasie (bph)-behandlung mittels holium-laser-enukleation der prostata (holep)
EP25164034.8A Pending EP4602999A3 (de) 2018-03-29 2019-03-28 Optimierung der bph-behandlung mit lochp (holium laser enukleation von prostrat)

Family Applications After (1)

Application Number Title Priority Date Filing Date
EP25164034.8A Pending EP4602999A3 (de) 2018-03-29 2019-03-28 Optimierung der bph-behandlung mit lochp (holium laser enukleation von prostrat)

Country Status (8)

Country Link
EP (2) EP3773299B1 (de)
JP (3) JP7177174B2 (de)
KR (4) KR102550642B1 (de)
CN (2) CN117958964A (de)
AU (3) AU2019245524A1 (de)
CA (1) CA3091389A1 (de)
IL (1) IL277198B2 (de)
WO (1) WO2019186564A1 (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR102550642B1 (ko) * 2018-03-29 2023-07-05 루메니스 리미티드 홀렙(HoLEP)을 이용한 양성전립선비대증(BPH) 치료의 최적화
CN114599300B (zh) 2019-11-12 2024-06-25 奥林巴斯株式会社 激光破碎装置用输出调整装置、激光破碎系统以及吸引力产生方法
US12564730B2 (en) * 2020-10-19 2026-03-03 Acclaro Corporation Laser surgical apparatus for performing treatment by irradiating a part to be treated by a variable pulsed laser beam
EP4251081A1 (de) * 2020-11-25 2023-10-04 Lumenis Ltd. Verfahren und system zur schätzung des abstands zwischen einem faserende und einem ziel
WO2025039065A1 (en) * 2023-08-24 2025-02-27 Solabio Inc. Method and system for the generation of ultrafast laser-based extended underwater channels
US20250064521A1 (en) * 2023-08-25 2025-02-27 Lumenis Ltd. Distance and size measurement system for pop-dusting efficiency

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH03278489A (ja) * 1990-02-14 1991-12-10 Nippon Koden Corp レーザ手術装置
FR2675371A1 (fr) * 1991-04-22 1992-10-23 Technomed Int Sa Dispositif de traitement thermique de tissus par groupe de sequence d'impulsions.
US5321715A (en) * 1993-05-04 1994-06-14 Coherent, Inc. Laser pulse format for penetrating an absorbing fluid
US5632739A (en) * 1994-10-13 1997-05-27 The General Hospital Corporation Two-pulse, lateral tissue illuminator
US6538739B1 (en) * 1997-09-30 2003-03-25 The Regents Of The University Of California Bubble diagnostics
CN102176878A (zh) * 2008-07-28 2011-09-07 科威中公司 用于接触型组织切除的多波长激光器和方法
EP2373381B8 (de) * 2008-12-02 2015-12-16 Biolitec unternehmensbeteilligungs ll AG Laserinduzierte dampf-/plasmavermittelte medizinische vorrichtung
WO2014139018A1 (en) 2013-03-15 2014-09-18 Synaptive Medical (Barbados) Inc. Context aware surgical systems
US20140336626A1 (en) 2013-05-10 2014-11-13 Advalue Photonics, Inc. Medical assembly using short pulse fiber laser
EP3127502B1 (de) 2015-08-03 2019-03-20 Fotona d.o.o. Reinigungssystem
KR20250133470A (ko) * 2016-06-09 2025-09-05 루메니스 리미티드 레이저 방사로 표적의 조사를 최적화하는 방법, 레이저 방사선으로 표적을 방사능 처리하는 방법 및 레이저 빔으로 조직을 치료하기 위한 의료용 레이저 시스템
KR102550642B1 (ko) * 2018-03-29 2023-07-05 루메니스 리미티드 홀렙(HoLEP)을 이용한 양성전립선비대증(BPH) 치료의 최적화

Also Published As

Publication number Publication date
WO2019186564A1 (en) 2019-10-03
EP3773299A4 (de) 2021-12-22
EP4602999A2 (de) 2025-08-20
CN111902100A (zh) 2020-11-06
KR20240152897A (ko) 2024-10-22
KR20200136017A (ko) 2020-12-04
IL277198A (en) 2020-10-29
EP3773299B1 (de) 2025-06-25
EP4602999A3 (de) 2025-10-22
JP2023011923A (ja) 2023-01-24
KR102907901B1 (ko) 2026-01-06
AU2021282522A1 (en) 2022-01-06
JP2021518237A (ja) 2021-08-02
JP2024114851A (ja) 2024-08-23
CN117958964A (zh) 2024-05-03
KR20230106713A (ko) 2023-07-13
KR102550642B1 (ko) 2023-07-05
KR102709378B1 (ko) 2024-09-25
JP7177174B2 (ja) 2022-11-22
AU2019245524A1 (en) 2020-09-10
CA3091389A1 (en) 2019-10-03
JP7512350B2 (ja) 2024-07-08
KR20260009948A (ko) 2026-01-20
IL277198B1 (en) 2025-03-01
IL277198B2 (en) 2025-07-01
AU2023210656B2 (en) 2025-06-26
CN111902100B (zh) 2024-03-19
AU2023210656A1 (en) 2023-08-24

Similar Documents

Publication Publication Date Title
US11419679B2 (en) Optimization of BPH treatment using LEP (laser enucleation of prostate)
EP3773299B1 (de) Optimierung einer benignen prostatahyperplasie (bph)-behandlung mittels holium-laser-enukleation der prostata (holep)
US20250099180A1 (en) Optimization of bph treatment using lep (laser enucleation of prostate)
US11478269B2 (en) Minimally invasive methods for multi-fluid tissue ablation
Wollin et al. The holmium laser in urology
US6953458B2 (en) Device and method for delivery of long wavelength laser energy to a tissue site
EP2259742B1 (de) Gewebeablation und kauterisation mit in einem flüssigkeitsstrom getragener optischer energie
EP2358286A1 (de) Dynamische laserimpulssysteme und verfahren

Legal Events

Date Code Title Description
STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE INTERNATIONAL PUBLICATION HAS BEEN MADE

PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: REQUEST FOR EXAMINATION WAS MADE

17P Request for examination filed

Effective date: 20200929

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

AX Request for extension of the european patent

Extension state: BA ME

DAV Request for validation of the european patent (deleted)
DAX Request for extension of the european patent (deleted)
A4 Supplementary search report drawn up and despatched

Effective date: 20211123

RIC1 Information provided on ipc code assigned before grant

Ipc: A61B 18/00 20060101ALN20211118BHEP

Ipc: A61B 17/00 20060101ALN20211118BHEP

Ipc: A61B 1/307 20060101ALI20211118BHEP

Ipc: A61B 1/07 20060101ALI20211118BHEP

Ipc: A61B 18/26 20060101ALI20211118BHEP

Ipc: A61B 18/24 20060101AFI20211118BHEP

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: EXAMINATION IS IN PROGRESS

17Q First examination report despatched

Effective date: 20240701

GRAP Despatch of communication of intention to grant a patent

Free format text: ORIGINAL CODE: EPIDOSNIGR1

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: GRANT OF PATENT IS INTENDED

RIC1 Information provided on ipc code assigned before grant

Ipc: A61B 18/00 20060101ALN20250128BHEP

Ipc: A61B 17/00 20060101ALN20250128BHEP

Ipc: A61B 1/307 20060101ALI20250128BHEP

Ipc: A61B 1/07 20060101ALI20250128BHEP

Ipc: A61B 18/26 20060101ALI20250128BHEP

Ipc: A61B 18/24 20060101AFI20250128BHEP

INTG Intention to grant announced

Effective date: 20250206

GRAS Grant fee paid

Free format text: ORIGINAL CODE: EPIDOSNIGR3

GRAA (expected) grant

Free format text: ORIGINAL CODE: 0009210

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE PATENT HAS BEEN GRANTED

RAP3 Party data changed (applicant data changed or rights of an application transferred)

Owner name: LUMENIS LTD.

AK Designated contracting states

Kind code of ref document: B1

Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

P01 Opt-out of the competence of the unified patent court (upc) registered

Free format text: CASE NUMBER: APP_24050/2025

Effective date: 20250520

REG Reference to a national code

Ref country code: GB

Ref legal event code: FG4D

REG Reference to a national code

Ref country code: CH

Ref legal event code: EP

REG Reference to a national code

Ref country code: CH

Ref legal event code: EP

REG Reference to a national code

Ref country code: IE

Ref legal event code: FG4D

REG Reference to a national code

Ref country code: DE

Ref legal event code: R096

Ref document number: 602019071599

Country of ref document: DE

REG Reference to a national code

Ref country code: NL

Ref legal event code: FP

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: FI

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20250625

REG Reference to a national code

Ref country code: LT

Ref legal event code: MG9D

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: GR

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20250926

Ref country code: NO

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20250925

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: BG

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20250625

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: HR

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20250625

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: RS

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20250925

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: LV

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20250625

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: PT

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20251027

REG Reference to a national code

Ref country code: AT

Ref legal event code: MK05

Ref document number: 1805666

Country of ref document: AT

Kind code of ref document: T

Effective date: 20250625

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: IS

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20251025

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: AT

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20250625

Ref country code: SM

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20250625

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: CZ

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20250625

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: PL

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20250625

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: EE

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20250625

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: SK

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20250625

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: ES

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20250625

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: NL

Payment date: 20260219

Year of fee payment: 8